Growth Metrics

Conmed (CNMD) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 240.25%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 240.25%
Dec 31, 2025 -76.01%
Sep 30, 2025 -51.71%
Jun 30, 2025 -59.58%
Mar 31, 2025 -43.93%
Dec 31, 2024 16.79%
Sep 30, 2024 36.61%
Jun 30, 2024 35.07%
Mar 31, 2024 52.16%
Dec 31, 2023 23.16%
Sep 30, 2023 94.09%
Jun 30, 2023 96.27%
Mar 31, 2023 -15.38%
Dec 31, 2022 -98.18%
Sep 30, 2022 -1,536.91%
Jun 30, 2022 -4,852.10%
Mar 31, 2022 -18.59%
Dec 31, 2021 -1.24%
Sep 30, 2021 -9,191.67%
Jun 30, 2021 20.20%
Mar 31, 2021 53.44%
Dec 31, 2020 64.45%
Sep 30, 2020 98.77%
Jun 30, 2020 24.72%
Mar 31, 2020 98.19%
Dec 31, 2019 -86.27%
Sep 30, 2019 -9.17%
Jun 30, 2019 -42.08%
Mar 31, 2019 -9,652.84%
Dec 31, 2018 -2.77%
Sep 30, 2018 73.97%
Jun 30, 2018 25.46%
Mar 31, 2018 -46.40%
Dec 31, 2017 -7.20%
Sep 30, 2017 -811.33%
Jun 30, 2017 4.04%
Mar 31, 2017 99.00%
Dec 31, 2016 36.33%
Sep 30, 2016 165.20%
Jun 30, 2016 45.35%
Mar 31, 2016 -5,174.99%
Dec 31, 2015 5.58%
Sep 30, 2015 23.88%
Jun 30, 2015 -96.09%
Mar 31, 2015 -20.89%
Dec 31, 2014 -46.76%
Sep 30, 2014 9.29%
Jun 30, 2014 -12.40%
Mar 31, 2014 1.57%
Dec 31, 2013 31.44%
Sep 30, 2013 76.84%
Jun 30, 2013 21.29%
Mar 31, 2013 94.15%
Dec 31, 2012 20.69%
Sep 30, 2012 -463.96%
Jun 30, 2012 -16.67%
Mar 31, 2012 -1,573.55%
Dec 31, 2011 -128.40%
Sep 30, 2011 -8.91%